Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma

Clinical trial NCT05411237 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05411237
Sponsor: AIDS Malignancy Consortium
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Kaposi Sarcoma HIV-1-infection AIDS-related Kaposi Sarcoma

Start date: 2026-09-01
Primary completion: 2029-09-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.